AFT-MXIV-08p: A clinical study to investigate the absorption, distribution, and elimination of Combogesic IV, and to evaluate its safety in pediatric patients with acute pain. (clinicaltrialsregister.eu) - Mar 16, 2026 - P2/3 | N=40 | Not yet recruiting | Sponsor: Aft Pharmaceuticals Limited
New P2/3 trial • Pain • Pediatrics
|